Cargando…

Immunological Aspects of Approved MS Therapeutics

Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading to disability in young adults. The outcome of the disease is unpredictable, and over time, neurological disabilities accumulate. Interferon beta-1b was the first drug to be approved in the 1990s for relapsing-rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rommer, Paulus S., Milo, Ron, Han, May H., Satyanarayan, Sammita, Sellner, Johann, Hauer, Larissa, Illes, Zsolt, Warnke, Clemens, Laurent, Sarah, Weber, Martin S., Zhang, Yinan, Stuve, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637731/ https://www.ncbi.nlm.nih.gov/pubmed/31354720 http://dx.doi.org/10.3389/fimmu.2019.01564

Ejemplares similares

Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies
por: Findling, Oliver, et al.
Publicado: (2020)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
por: Hauer, Larissa, et al.
Publicado: (2022)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications
por: Hauer, Larissa, et al.
Publicado: (2020)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
por: Warnke, Clemens, et al.
Publicado: (2010)

Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011)

Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
por: Feige, Julia, et al.
Publicado: (2020)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature
por: Nardone, Raffaele, et al.
Publicado: (2020)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review
por: Hauer, Larissa, et al.
Publicado: (2019)

Relapsing and progressive MS: the sex-specific perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020)

B-cell–targeted therapies in relapsing forms of MS
por: Dubey, Divyanshu, et al.
Publicado: (2017)

Therapy of Dysphagia by Prolonged Pharyngeal Electrical Stimulation (Phagenyx) in a Patient with Brainstem Infarction
por: Florea, Cristina, et al.
Publicado: (2020)

Intracranial Vertebrobasilar Calcification in Patients with Ischemic Stroke Is a Predictor of Recurrent Stroke, Vascular Disease, and Death: A Case-Control Study
por: Magdič, Jožef, et al.
Publicado: (2020)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Herpes Simplex Virus Type 2 Myelitis: Case Report and Review of the Literature
por: Nardone, Raffaele, et al.
Publicado: (2017)

Correction to: FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients
por: Goldman, Myla D., et al.
Publicado: (2020)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Effects of Repetitive Transcranial Magnetic Stimulation over Prefrontal Cortex on Attention in Psychiatric Disorders: A Systematic Review
por: Hauer, Larissa, et al.
Publicado: (2019)

Contribution of Serum Lipid Profiles to Outcome After Endovascular Thrombectomy for Anterior Circulation Ischemic Stroke
por: Pikija, Slaven, et al.
Publicado: (2018)

Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke
por: Pikija, Slaven, et al.
Publicado: (2018)

Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
por: Satyanarayan, Sammita, et al.
Publicado: (2022)

Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
por: Manouchehri, Navid, et al.
Publicado: (2022)

Intracranial Thrombus Morphology and Composition Undergoes Time-Dependent Changes in Acute Ischemic Stroke: A CT Densitometry Study
por: Pikija, Slaven, et al.
Publicado: (2016)

Proximal flow to middle cerebral artery is associated with higher thrombus density in terminal internal carotid artery occlusion
por: Pikija, Slaven, et al.
Publicado: (2017)

A MS‐lesion pattern discrimination plot based on geostatistics
por: Marschallinger, Robert, et al.
Publicado: (2016)

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
por: Altmann, Patrick, et al.
Publicado: (2022)

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
por: Katz Sand, Ilana, et al.
Publicado: (2023)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis
por: Harutyunyan, Gayane, et al.
Publicado: (2017)

Autoimmune Encephalitis at the Neurological Intensive Care Unit: Etiologies, Reasons for Admission and Survival
por: Harutyunyan, Gayane, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ki0sgk27h9flb80i6jvec9pnv